Effects of nicotine on cardiovascular remodeling in a mouse model of systemic hypertension

Cardiovascular Toxicology

Volumn 13, Issue 4, 2013, Pages 364-369

  Colombo, E Sage ^a   Davis, Joshua ^a   Makvandi, Mehran ^a   Aragon, Mario ^a   Lucas, Selita N ^a   Paffett, Michael L ^a   Campen, Matthew J ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

Angiotensin II; Cardiovascular toxicity; E cigarettes; Electronic nicotine delivery systems; Vascular remodeling

Indexed keywords

ANGIOTENSIN II; GELATINASE A; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOTOXICITY; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; HEART DEVELOPMENT; HEART HYPERTROPHY; HEART MUSCLE; HEART WEIGHT; HISTOPATHOLOGY; HYPERTENSION; LONG TERM EXPOSURE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

MUS;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; DISEASE MODELS, ANIMAL; HYPERTENSION; INFUSION PUMPS; MALE; MICE; MICE, INBRED C57BL; NICOTINE; TREATMENT OUTCOME; VENTRICULAR REMODELING;

EID: 84890550413     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-013-9217-z     Document Type: Article

References (27)

1. CDC Vital Signs: Current cigarette smoking among adults aged ≥18 years - United States, 2005-2010. Accessed 12/10/2012. www.cdc.gov/tobacco/data- statistics/fact-sheets/cessation/quitting/index.htm.
2. Krupski, W. C.; Olive, G. C.; Weber, C. A.; & Rapp, J. H. (1987). Comparative effects of hypertension and nicotine on injury induced myointimal thickening. Surgery, 102, 409-415.
3. Benowitz, N. L.; Hansson, A.; & Jacob, P.; I. I. I. (2002). Cardiovascular effects of nasal and transdermal nicotine and cigarette smoking. Hypertension, 39, 1107-1112.
4. Fishebein, L.; O'Brien, P.; Hutson, A.; Theriaque, D.; Stacpoole, P. W.; & Flotte, T. (2000). Pharmacokinetics and pharmacodynamic effects of nicotine nasal spray devices on cardiovascular and pulmonary function. Journal of Investigative Medicine, 48, 435-440.
5. Martins, L. C.; Ferreira-Melo, S. E.; Sabha, M.; Coelho, O. R.; Yugar-Toledo, J. C.; Quinaglia, T.; et al. (2009). Acute effects of pharmacotherapies in blood pressure in normotensive moderate smokers. Blood Pressure, 18(4), 255-260.
6. Mundal, H. H.; Hjemdahl, P.; & Ghesdal, K. (1995). Acute effects of low dose nicotine gum on platelet function in non-smoking hypertensive and normotensive men. European Journal of Clinical Pharmacology, 41, 411-416.
7. Yugar-Toledo, J. C.; Ferreira-Melo, E.; Sabha, M.; Nogueira, E. A.; Coelho, O.; Colombo, F. M. C.; et al. (2005). Blood pressure circadian rhythm and endothelial function in heavy smokers: Acute effects of transdermal nicotine. Journal of Clinical Hypertension, 7, 721-729.
8. Khoury, Z.; Comans, P.; Lerer, K.; Gavish, A.; & Tzivoni, D. (1996). Effects of transdermal nicotine patches on ambulatory ecg monitoring findings: A double-blind study in healthy smokers. Cardiovascular Drugs and Therapy, 10, 179-184.
9. Mahmarian, J. J.; Moye, L. A.; Nasser, G. A.; Nagueh, S. F.; Bloom, M. F.; Benowitz, N. L.; et al. (1997). Nicotine patch therapy in smoking cessation reduces the extent of exercise-induced myocardial ischemia. Journal of the American College of Cardiology, 30, 125-130.
10. Tanus-Santos, J. E.; Toledo, J. C.; Cittadiono, M.; Sabha, M.; Rocha, J. C.; & Moreno, H.; Jr. (2001). Cardiovascular effects of transdermal nicotine in mildly hypertensive smokers. American Journal of Hypertension, 14, 601-614.
11. Thorup, C.; Jose, C. L.; Gross, S. S.; Moore, L. C.; & Goligorsky, M. S. (1999). Carbon monoxide induces vasodilation and nitric oxide release but suppresses endothelial NOS. American Journal of Physiology, 277, F882-F889.
12. Zornoff, L. A.; Matsubara, L. S.; Matsubara, B. B.; Okoshi, M. P.; Okoshi, K.; Dal Pai-Silva, M.; et al. (2006). Beta-carotene supplementation attenuates cardiac remodeling induced by one-month tobacco-smoke exposure in rats. Toxicological Sciences, 90, 259-266.
13. Meurrens, K.; Ruf, S.; Ross, G.; Schleef, R.; von Holt, K.; & Schlüter, K. D. (2007). Smoking accelerates the progression of hypertension-induced myocardial hypertrophy to heart failure in spontaneously hypertensive rats. Cardiovascular Research, 76, 311-322.
14. Danser, J.; van Kesteren, C.; Bax, W.; Tavenier, M.; Derkx, F.; Saxena, P.; et al. (1997). Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts: Evidence for renin binding. Circulation, 96, 220-226.
15. Iwata, M.; Cowling, R.; Yeo, S.; & Greenberg, B. (2011). Targeting the ACE2-Ang-(1-7) pathway in cardiac fibroblasts to treat cardiac remodeling and heart failure. Journal of Molecular and Cellular Cardiology, 51, 542-547.
16. Malayeri, A. A.; Natori, S.; Bahrami, H.; Bertoni, A. G.; Kronmal, R.; Lima, J. A.; et al. (2008). Relation of aortic wall thickness and distensibility to cardiovascular risk factors (from the multi-ethnic study of atherosclerosis (MESA)). American Journal of Cardiology, 102, 491-496.
17. Schluter, K. D.; & Wenzel, S. (2008). Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks. Pharmacology & Therapeutics, 119, 311-325.
18. Wang, S.; Zhang, C.; Zhang, M.; Liang, B.; Zhu, H.; Lee, J.; et al. (2012). Activation of AMP-activated protein kinase α2 by Nic instigates formation of abdominal aortic aneurysms in mice in vivo. Nature Medicine, 18, 902-910.
19. Zhang, S.; Day, I.; & Ye, S. (2001). Nicotine-induced changes in gene expression by human coronary artery endothelial cells. Atherosclerosis, 154, 277-283.
20. Osergren, J. B. (2006). Angiotensin receptor blockade with candesartan in heart failure: Findings from the candesartan in heart failure-assessment of reduction in mortality and morbidity (CHARM) programme. Journal of Hypertension, 24(suppl), S3-S7.
21. Fernie, J. M.; Douglas, A. N.; Lamb, D.; & Ruckley, V. A. (1983). Right ventricular hypertrophy in a group of coal workers. Thorax, 38, 436-442.
22. Li, J. M.; Cui, T. X.; Shiuch, T.; Liu, H. W.; Min, L. J.; Okumura, M.; et al. (2004). Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts. Arteriosclerosis, Thrombosis, and Vascular Biology, 24, 80-84.
23. Shasha, S. M.; Damal, H.; Kristal, B.; Galetzky, G.; Roguin, N.; & Shkolnik, T. (1993). Red cell filterability in cigarette smokers and its relations to cardiac hypertrophy. Atherosclerosis, 98, 91-98.
24. A receptor antagonism attenuates carbon monoxide-induced myocardial hypertrophy in rat. Toxicology and Applied Pharmacology, 178, 8-14.
25. Castardeli, E.; Duarte, D.; Minicucci, M.; Azevedo, P.; Matsubara, B.; Matusbara, L.; et al. (2007). Tobacco smoke-induced left ventricular remodelling is not associated with metalloproteinase-2 or -9 activation. European Journal of Heart Failure, 9, 1081-1085.
26. O'Callagan, C.; & Williams, B. (2000). Mechanical strain-induced extracellular matrix production by human vascular smooth muscle cells. Hypertension, 36, 319-324.
27. Matta, S. G.; Balfour, D. J.; Benowitz, N. L.; Boyd, R. T.; Buccafusco, J. J.; Caggiula, A. R.; et al. (2007). Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl), 190, 269-319.